Thallasmia

733
-1

Published on

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
733
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
19
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Thallasmia

  1. 1. "Pleasure in the job puts perfection in thework." -- Aristotle :
  2. 2. Hemoglobinopathiesare disorders affecting the structure, function or production of hemoglobin
  3. 3. Thalassemia is one of them
  4. 4. Thalassemia• Hemoglobin• Haem + Globin• Globin – 4 chains - , , ,■ - 3 Types• HbA (Normal Hemoglobin- 2 2)• HbF ( o• HbA2 (A2• 2 )• Each chain has specific aminoacid combination• When aminoacids altered by deletion or addition, mutation –abnormal hemoglobins are formed.
  5. 5. Thalassemia• Hemoglobin critical for normal oxygen delivery totissues• Normal RBC life span – 120 days• Hemoglobin is present in erythrocytes in such highquantities that it can alter red cell shape, deformability andviscosity.
  6. 6. Hemoglobin Review• Each complex consists of : – Four polypeptide chains, non-covalently bound – Four heme complexes with iron bound – Four O2 binding sites
  7. 7. Globin Chains• Alpha Globin – 141 amino acids – Coded for on Chromosome 16 – Found in normal adult hemoglobin, A1 and A2• Beta Globin – 146 amino acids – Coded for on Chromosome 11, found in Hgb A1• Delta Globin – Found in Hemoglobin A2--small amounts in all adults• Gamma Globin – Found in Fetal Hemoglobin• Zeta Globin – Found in embryonic hemoglobin
  8. 8. Hemoglobin Types Hemoglobin Type Globin Chains• Hgb A1—92%--------- α2β2• Hgb A2—2.5%-------- α2δ2• Hgb F — <1%--------- α2γ2• Hgb H ------------------ β4• Bart’s Hgb-------------- γ4• Hgb S-------------------- α2β26 gluval• Hgb C------------------- α2β26 glulys
  9. 9. Thalassemia• Thalassemias are genetic disorders in which synthesisof normal polypeptide chain forming adult hemoglobinis suppressed.• Selective deficiency of one or more polypeptidechains have two consequences• 1. R Hb – Anemia & e• 2. Cell Membrane damage leading to prematuredestruction of cells
  10. 10. 2 -Thalassemia• Decreased production of chains.• Total 4 genes code for 4 chains• 2 genes on each chromosome 16
  11. 11. Types of Thalassemia• 2 Classifications• First Type a. Thalassemia Major (Profound Anemia) b. Thalassemia Intermediate c. Thalassemia Minor d. Thalassemia Minima• Second Type a. Alpha Thalassemia b. Beta Thalassemia
  12. 12. > -Thalassemia -Thalassemia• Classification - -Thalassemia 2 trait (One of 4 genes deleted) - -Thalassemia 1 trait (Two of 4 genes deleted) - HbH disease > Three genes deleted > No specific treatment required > Avoid iron therapy > Folic acid if necessary - Hydrops fetalis (Hb Bart’s) > All 4 genes deleted > In utero death of foetus > No treatment available
  13. 13. Alpha Thalassemias• Result from gene deletions• One deletion—Silent carrier; no clinical significance• Two deletions—α Thal trait; mild hypochromic microcytic anemia• Three deletions—Hgb H; variable severity, but less severe than Beta Thal Major• Four deletions—Bart’s Hgb; Hydrops Fetalis; In Utero or early neonatal death
  14. 14. Alpha Thalassemias• Usually no treatment indicated• 4 deletions incompatible with life• 3 or fewer deletions have only mild anemia
  15. 15. Beta Thalassemia• Point mutation in gene for non alpha producing chain inchromosome 11- Two types• Beta Thalassemia Major ( r 0 )• Beta Thalassemia Minor ( r - )
  16. 16. Beta Thalassemia Major Also called Cooley’s Anemia • Clinical Features - Severe hypochromic anemia - Erythroblastosis - Grossly b l HbA - Increase in HbF
  17. 17. Beta Thalassemia Major• Treatment - Bone Marrow transplantation - Avoid Iron therapy - If iron overload, Desferoximine therapy - Splenectomy
  18. 18. Beta Thalassemia Minor• Clinical Features - Mild anemia - Some target cells - Punctate basophilia - resistance of RBC to osmotic lysis
  19. 19. β-Thalassemia Major--Treatment• Chronic Transfusion Therapy – Maximizes growth and development – Suppresses the patient’s own ineffective erythropoiesis and excessive dietary iron absorption – PRBC transfusions often monthly to maintain Hgb 10-12• Chelation Therapy – Binds free iron and reduces hemosiderin deposits – 8-hour subcutaneous infusion of deferoxamine, 5 nights/week – Start after 1year of chronic transfusions or ferritin>1000 ng/dl• Splenectomy--indications – Trasfusion requirements increase 50% in 6mo – PRBCs per year >250cc/kg – Severe leukopenia or thrombocytopenia
  20. 20. β-Thalassemia MajorComplications and Emergencies• Sepsis—Encapsulated organisms – Strep Pneumo• Cardiomyopathy—presentation in CHF – Use diuretics, digoxin, and deferoxamine• Endocrinopathies—presentation in DKA – Take care during hydration so as not to precipitate CHF from fluid overload
  21. 21. How to Prevent ThalassemiaThis disease is inherited. Blood tests andfamily genetic studies will show if you area carrier. A genetic counselor can discussrisks of passing on the disease. They canalso give you information on testing.
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×